Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Menopausal Hot Flashes Market, by Region, 2019-2029 (USD Billion)
1.2.2. Menopausal Hot Flashes Market, by Treatment Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Menopausal Hot Flashes Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Menopausal Hot Flashes Market Dynamics
3.1. Menopausal Hot Flashes Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing awareness about menopause and its treatment
3.1.1.2. Increasing research supporting advantages of dietary supplements
3.1.2. Market Challenges
3.1.2.1. Availability of Generic Medicines
3.1.2.2. Side Effects Associated with Hormonal Products
3.1.3. Market Opportunities
3.1.3.1. Development of advanced products
Chapter 4. Global Menopausal Hot Flashes Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Menopausal Hot Flashes Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Menopausal Hot Flashes Market by Treatment Type, Performance - Potential Analysis
6.3. Global Menopausal Hot Flashes Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
6.4. Menopausal Hot Flashes Market, Sub Segment Analysis
6.4.1. Non-hormonal Treatment
6.4.2. Hormonal Treatment
Chapter 7. Global Menopausal Hot Flashes Market, Regional Analysis
7.1. Menopausal Hot Flashes Market, Regional Market Snapshot
7.2. North America Menopausal Hot Flashes Market
7.2.1. U.S. Menopausal Hot Flashes Market
7.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Menopausal Hot Flashes Market
7.3. Europe Menopausal Hot Flashes Market Snapshot
7.3.1. U.K. Menopausal Hot Flashes Market
7.3.2. Germany Menopausal Hot Flashes Market
7.3.3. France Menopausal Hot Flashes Market
7.3.4. Spain Menopausal Hot Flashes Market
7.3.5. Italy Menopausal Hot Flashes Market
7.3.6. Rest of Europe Menopausal Hot Flashes Market
7.4. Asia-Pacific Menopausal Hot Flashes Market Snapshot
7.4.1. China Menopausal Hot Flashes Market
7.4.2. India Menopausal Hot Flashes Market
7.4.3. Japan Menopausal Hot Flashes Market
7.4.4. Australia Menopausal Hot Flashes Market
7.4.5. South Korea Menopausal Hot Flashes Market
7.4.6. Rest of Asia Pacific Menopausal Hot Flashes Market
7.5. Latin America Menopausal Hot Flashes Market Snapshot
7.5.1. Brazil Menopausal Hot Flashes Market
7.5.2. Mexico Menopausal Hot Flashes Market
7.6. Rest of The World Menopausal Hot Flashes Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bristol-Myers Squibb Company
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Novartis AG
8.2.3. Teva Pharmaceutical Industries Ltd
8.2.4. Hisamitsu Pharmaceutical Co. Inc.
8.2.5. AstraZeneca PLC
8.2.6. Agile Therapeutics
8.2.7. Novo Nordisk Corporation
8.2.8. Pfizer Inc.
8.2.9. Merck & Co. Inc.
8.2.10. Ferring BV
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption